Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- CBA cell-based SEAP secreted alkaline phosphatase FFAR 4 GPR 120 G protein coupled receptor Gaq Gas transfection complex FFAR4 GPR120 free fatty acid FFAR4S
- Product Overview:
Free fatty acid receptor 4 (FFAR4)/GPR120 is a G protein-coupled receptor for long chain fatty acids such as docosahexaenoic acid and eicosapentaenoic acid ?-3 fatty acids. It is involved in the regulation of glucose uptake in adipocytes and mediates anti-inflammatory activity in macrophages. Cayman’s FFAR4 (GPR120) Reporter Assay Kit consists of a 96-well plate coated with a transfection complex containing DNA constructs for the short isoform of FFAR4 (FFAR4S), an engineered G protein that directs G?q activation signals to the G?s pathway, and a cAMP response element-regulated secreted alkaline phosphatase (SEAP) reporter (FFAR4 reverse transfection strip plate). Cells grown on the transfection complex will express FFAR4S at the cell surface and the recombinant G protein inside the cell. Binding of agonists to FFAR4S initiates a signal transduction cascade resulting in expression of SEAP which is secreted into the cell culture medium. Aliquots of culture medium are collected 16-24 hours after stimulation and SEAP activity is measured following addition of a luminescence-based alkaline phosphatase substrate provided in the kit. The kit is easy to use and can be readily applied to high-throughput screening for therapeutic compounds regulating activation of FFAR4S. A known FFAR4 agonist, GSK137647A1, is included in the kit for use as a positive control. The kit provides sufficient reagent to measure SEAP activity at three time points using the three included white assay plates.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.